ROIV is trading 4.3% down today at $31.03 as the stock undergoes normal profit-taking and consolidation following a sharp rally in the prior session.
- Shares jumped 14.89% on May 20, 2026, after the company reported upbeat earnings driven by a significant Moderna litigation gain.
- The previous surge was further supported by strong pipeline commentary provided during the earnings update.
- Today's pullback occurs amid a lack of new company-specific headlines and a broader market that is also trading modestly lower.